Insulin aspart, recombinant Subcutaneous and Migranal nasal
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Migranal nasal and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: dihydroergotamine
Brand name: Migranal, DHE. 45
Synonyms: Migranal (nasal), Migranal
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-MigraTen
- Insulin aspart, recombinant Subcutaneous-Milantex
- Insulin aspart, recombinant Subcutaneous-Mili
- Insulin aspart, recombinant Subcutaneous-Mili Tablets
- Insulin aspart, recombinant Subcutaneous-Milk of Magnesia
- Insulin aspart, recombinant Subcutaneous-Milk thistle
- Migranal nasal-Insulin degludec
- Migranal nasal-Insulin Degludec (U-100) Prefilled Pens
- Migranal nasal-Insulin Degludec (U-100) Vials
- Migranal nasal-Insulin Degludec (U-200) Prefilled Pens
- Migranal nasal-Insulin degludec and liraglutide
- Migranal nasal-Insulin degludec and liraglutide Subcutaneous